AstraZeneca to build plant in Singapore
Global biopharmaceutical company AstraZeneca intends to build a US$1.5bil manufacturing facility in Singapore, the company says.
Global biopharmaceutical company AstraZeneca intends to build a US$1.5bil manufacturing facility in Singapore, the company says.
JPMorgan Chase CEO Jamie Dimon is telling investors the bank’s succession plans are underway, while warning investors yesterday about risks…
Amid the surging wave of telecommunications and technology stocks on the Vietnamese stock market, Viettel Global Investment JSC (VGI) has…
Vietnam’s retail real estate market is thriving in terms of scale and quality, with occupancy rates above 90% in major…
Ivan Boesky, the financier who gave birth to the “greed is good” mantra before going to prison in one of…
Public Bank Bhd, which reported a 3.5% year-on-year decrease in its first quarter (1Q24) net profit, is maintaining modest targets…
WASHINGTON/AMELIA ISLAND: Federal Reserve policymakers said on Tuesday the U.S. central bank should wait several more months to ensure that inflation…
KUALA LUMPUR: CIMB Treasury and Markets Research anticipates the rollout of fuel subsidy rationalisation to commence in mid-June 2024 at the earliest.
LONDON: British retailer Marks & Spencer reported a 58% rise in annual profit, ahead of market expectations, as its strategy…